ClinicalTrials.Veeva

Menu

Analysis of Thrombo-embolic Complications After Endovascular Treatment of Unruptured Intracranial Aneurysms (ACET)

C

CHU de Reims

Status

Completed

Conditions

Unruptured Intracranial Aneurysms

Treatments

Other: diffusion-weighted MRI and clinical examination

Study type

Interventional

Funder types

Other

Identifiers

NCT02862756
PR16021*

Details and patient eligibility

About

Endovascular treatment of ruptured and unruptured intracranial aneurysms presents complications, mainly the thrombo-embolic complication. No specific studies have been conducted to study factors associated with the occurrence of thromboembolic complications (symptomatic or not) post endovascular treatment of intracranial aneurysms.

Full description

In this multicenter, prospective study, patients with treatment of unruptured intracranial aneurysms will be recruited. The thromboembolic complications will be research using diffusion-weighted MRI.

Enrollment

250 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patient having a programmed endovascular treatment for unruptured intracranial aneurysm
  • patient older than 18 years
  • patient consenting to participate to the study
  • patient enrolled in the national healthcare insurance program

Exclusion criteria

  • patients with contraindications for MRI
  • patients whose clinical condition does not allow sufficient cooperation to the realization of MRI
  • patients with arteriovenous malformation intracranial

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

250 participants in 1 patient group

patient with endovascular treatment
Experimental group
Treatment:
Other: diffusion-weighted MRI and clinical examination

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems